Disease Landscape and Forecast Insights
Comprehensive market intelligence and actionable insights help you optimize your long-term disease strategy
Report
November 12, 2020
Diabetic Macular Edema/Diabetic Retinopathy | Disease Landscape and Forecast | G7 | 2020
The DR / DME therapy market will grow moderately over the forecast period (6.6% annual growth through 2029); this growth will be due largely to: The launch of five new therapeutic options…
Report
November 10, 2020
Myelodysplastic Syndromes | Niche & Rare Disease Landscape & Forecast | US/EU5 | 2020
Myelodysplastic syndromes (MDS) are a heterogeneous collection of hematopoietic stem cell disorders that result in cytopenias and the risk of progression to acute myeloid leukemia (AML). Although…
Report
November 5, 2020
Rare Diseases and Orphan Drugs | Disease Landscape & Forecast | Gene Therapies | G7 | 2020
Approximately 80% of rare diseases have a genetic etiology. Gene therapies hold the potential to transform the treatment of rare diseases and may provide a functional cure for some. However, these…
